<p>Rentokil Initial（LSE：RTO）的股價在公司最新宣佈盈利預期下調後暴跌了多達 20％，主要原因是其北美市場銷售數據令人失望。這標誌着 Rentokil 在過去一年內第三次就這一關鍵地區的困境發出警告。</p>
<p>在與利益相關者舉行的電話會議中，首席執行官安迪·蘭索姆對公司旨在提高收入的戰略執行表達了明顯的挫敗感，該戰略是在幾個月前的三月份啓動的。然而，他表現出對該戰略本身的堅定承諾，肯定儘管遭遇挫折，也不會做出任何改變。</p>
<p>這一最新盈利預期的影響是嚴重的，因為 Rentokil 的股價自去年 10 月關於北美的首次盈利警告以來已經貶值了近 33％。具體來説，截至 GMT 時間 0800 時，股價約為 380 便士，使其成為富時 100 指數中最大的輸家。</p>
<p>強調北美市場的重要性，Rentokil 去年約 60％的收入來自該地區。作為對持續挑戰的回應，公司宣佈裁員其美國員工，儘管具體裁員人數尚未公佈。</p>
<p>Rentokil 現在的預測預計全年調整前税前利潤約為 7 億英鎊（約合 9.16 億美元），較去年報告的 7.66 億英鎊下降，低於 RBC 資本市場對 7.77 億英鎊的估計。此外，公司在北美的有機收入增長預計在下半年將約為 1％，遠低於早期預測的 2-4％的增長率。</p>
<p>2021 年收購的美國競爭對手 Terminix 的整合對 Rentokil 構成了持續挑戰，顯示出源自該交易的輕微干擾影響了有機增長。自發出最初警告以來，公司市值已經縮水約 54 億英鎊。</p>
<p>分析師預測，這一最近的盈利警告可能加劇對 Rentokil 在北美管理和運營監督的審查。公司已經採取了增加營銷支出的舉措，以吸引更多客户，但這一戰略是否會產生預期的結果尚待觀察。</p>
<p>更增添了一層神秘感，著名激進投資者納爾遜·佩爾茨通過 Trian Fund Management 在 Rentokil 建立了一定股權，並表示有興趣討論可能重塑公司方向的&#34;想法和舉措&#34;。與 Rollins（NYSE：ROL）一起，Rentokil 構成了美國害蟲控制行業的重要組成部分，Rentokil 自合併以來一直是該行業的主導者。</p>

<p>Rentokil Initial 的股價在公司宣佈由於北美銷售疲軟而降低利潤預期後下跌了 20%，這標誌着該公司在一年內的第三次利潤預警。儘管感到沮喪，CEO Andy Ransom 仍然致力於當前的戰略。公司全年調整前税前利潤預測現為 7 億英鎊，低於去年的 7.66 億英鎊。自第一次預警以來，Rentokil 的市值已經減少 54 億英鎊，並且已經宣佈在美國裁員。激進投資者 Nelson Peltz 已經持有該公司股份，尋求討論潛在的變革</p>

<p>Shares of Rentokil Initial (LSE: RTO) plummeted by as much as 20% following the company's latest announcement of reduced profit expectations, primarily attributed to disappointing sales figures from its North American market. This marked the third time within the past year that Rentokil has sounded the alarm regarding struggles in this key region.</p>
<div class="lb-trans"><p>Rentokil Initial（LSE：RTO）的股價在公司最新宣佈盈利預期下調後暴跌了多達 20％，主要原因是其北美市場銷售數據令人失望。這標誌着 Rentokil 在過去一年內第三次就這一關鍵地區的困境發出警告。</p>
</div><p>In a conference call with stakeholders, CEO Andy Ransom expressed palpable frustration about the company's strategic execution aimed at boosting revenue, which was initiated just a few months ago in March. However, he displayed a steadfast commitment to the strategy itself, affirming that no changes would be made despite the setbacks.</p>
<div class="lb-trans"><p>在與利益相關者舉行的電話會議中，首席執行官安迪·蘭索姆對公司旨在提高收入的戰略執行表達了明顯的挫敗感，該戰略是在幾個月前的三月份啓動的。然而，他表現出對該戰略本身的堅定承諾，肯定儘管遭遇挫折，也不會做出任何改變。</p>
</div><p>The impact of this latest earnings forecast has been severe, as Rentokil's shares have now depreciated nearly 33% since the first profit warning concerning North America back in October of last year. Specifically, shares were trading around 380 pence as of 0800 GMT, making them the most significant loser on the FTSE 100 index.</p>
<div class="lb-trans"><p>這一最新盈利預期的影響是嚴重的，因為 Rentokil 的股價自去年 10 月關於北美的首次盈利警告以來已經貶值了近 33％。具體來説，截至 GMT 時間 0800 時，股價約為 380 便士，使其成為富時 100 指數中最大的輸家。</p>
</div><p>Highlighting the importance of the North American market, Rentokil derived approximately 60% of its revenue from this region last year. In response to the ongoing challenges, the company announced layoffs within its U.S. workforce, though the specific number of job cuts remains undisclosed.</p>
<div class="lb-trans"><p>強調北美市場的重要性，Rentokil 去年約 60％的收入來自該地區。作為對持續挑戰的回應，公司宣佈裁員其美國員工，儘管具體裁員人數尚未公佈。</p>
</div><p>Rentokil's forecast now anticipates a full-year adjusted pretax profit of roughly £700 million (approximately $916 million), a decline from the £766 million reported last year and falling shy of RBC Capital Markets' estimate of £777 million. Furthermore, the firm's organic revenue growth in North America is projected to be around 1% for the latter half of the year, significantly lower than the earlier predictions that suggested a growth rate within the 2-4% range.</p>
<div class="lb-trans"><p>Rentokil 現在的預測預計全年調整前税前利潤約為 7 億英鎊（約合 9.16 億美元），較去年報告的 7.66 億英鎊下降，低於 RBC 資本市場對 7.77 億英鎊的估計。此外，公司在北美的有機收入增長預計在下半年將約為 1％，遠低於早期預測的 2-4％的增長率。</p>
</div><p>The integration of Terminix, a U.S. rival acquired in 2021, has posed an ongoing challenge for Rentokil, with indications of modest disruptions impacting organic growth stemming from this deal. The company has seen its market capitalization shrink by approximately £5.4 billion since the initial warning was issued.</p>
<div class="lb-trans"><p>2021 年收購的美國競爭對手 Terminix 的整合對 Rentokil 構成了持續挑戰，顯示出源自該交易的輕微干擾影響了有機增長。自發出最初警告以來，公司市值已經縮水約 54 億英鎊。</p>
</div><p>Analysts predict that this recent profit warning could intensify scrutiny on Rentokil's management and its operational oversight in North America. Increasing marketing expenditures have been adopted in a bid to lure in more customers, but whether this strategy will yield the desired results remains to be seen.</p>
<div class="lb-trans"><p>分析師預測，這一最近的盈利警告可能加劇對 Rentokil 在北美管理和運營監督的審查。公司已經採取了增加營銷支出的舉措，以吸引更多客户，但這一戰略是否會產生預期的結果尚待觀察。</p>
</div><p>Adding yet another layer of intrigue, renowned activist investor Nelson Peltz, through Trian Fund Management, has established a stake in Rentokil and has expressed interest in discussing potential &#34;ideas and initiatives&#34; that could reshape the company's direction. Together with Rollins (NYSE: ROL), Rentokil forms a significant part of the U.S. pest control sector, where Rentokil has emerged as the dominant player since its merger.</p>
<div class="lb-trans"><p>更增添了一層神秘感，著名激進投資者納爾遜·佩爾茨通過 Trian Fund Management 在 Rentokil 建立了一定股權，並表示有興趣討論可能重塑公司方向的&#34;想法和舉措&#34;。與 Rollins（NYSE：ROL）一起，Rentokil 構成了美國害蟲控制行業的重要組成部分，Rentokil 自合併以來一直是該行業的主導者。</p>
</div>

Rentokil 的股價暴跌 20%，北美地區的困境持續：深入分析利潤警告和未來前景